Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Girona France (2004)

Organization Overview

First Clinical Trial
2006
NCT00369096
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Berta Alemany | Cristina Martinez | Doctor Joseh Trueta, Girona university clinical Hospital | Hospital Dr Josep Trueta | Hospital Dr Josep Trueta and Hospital Santa Caterina | Hospital Josep Trueta | Hospital Josep Trueta, Girona, Spain | Hospital Universitari de Girona Doctor Josep Trueta | Hospital Universitari de Girona DrJosep Trueta | Hospital Universitari Josep Trueta/Hospital Santa Caterina, Girona/Salt, Spain | IDIBGI (Institut d'Investigació Biomèdica de Girona Dr. Trueta) | Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta | Servicio de Nefrologia del Hospital Josep Trueta (Gerona - Spain)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiac Output, Low (Phase 3)

Colonic Neoplasms (Phase 4)

Critical Illness (Phase 4)

Crohn Disease (Phase 3)

Cross Infection (Phase 4)

Hemorrhage (Phase 3)

Multiple Trauma (Phase 2)

Neoplasm Metastasis (Phase 4)

Neoplasms, Second Primary (Phase 4)

Pain, Postoperative (Phase 4)

Peritoneal Diseases (Phase 2)

Pneumonia (Phase 3)

Sepsis (Phase 3)

Shock (Phase 3)

Shock, Hemorrhagic (Phase 3)

Shock, Septic (Phase 3)

Status Epilepticus (Phase 3)

Stroke (Phase 1)

Toxemia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 28